Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001385116-08-000002
Filing Date
2008-05-14
Accepted
2008-05-14 17:24:56
Documents
1
Period of Report
2008-05-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 9405
  Complete submission text file 0001385116-08-000002.txt   11515
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 21000
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 21000 972-4-988-9488
Protalix BioTherapeutics, Inc. (Issuer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O PROTALIX BIOTHERAPEUTICS, INC. 2 SNUNIT ST, SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 972-4-988-9488
Almon Einat Brill (Reporting) CIK: 0001385116 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33357 | Film No.: 08833003